Mild polypharmacy and MCI progression in older adults: the mediation effect of drug–drug interactions
- 22 November 2019
- journal article
- research article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (1) , 49-56
Abstract
Polypharmacy has been associated with worse cognitive performance, but its impact on mild cognitive impairment (MCI) progression to dementia has not been explored.Keywords
Funding Information
- Special Program of the Ministry of Health (Special program ex art. 12, comma 2, lett B D.Lvo n. 502/92)
- National Research Council of Italy (Prot. MIUR 2867 25.11.2011)
This publication has 33 references indexed in Scilit:
- Interventions to improve the appropriate use of polypharmacy for older peopleCochrane Database of Systematic Reviews, 2018
- Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-AnalysisJournal of the American Medical Directors Association, 2016
- Aging and the Burden of Multimorbidity: Associations With Inflammatory and Anabolic Hormonal BiomarkersThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2014
- The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based CohortPLOS ONE, 2013
- Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing StudyJournal of the American Geriatrics Society, 2011
- Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three‐year period in an elderly populationPharmacoepidemiology and Drug Safety, 2011
- Impact of Anticholinergics on the Aging Brain: A Review and Practical ApplicationAging Health, 2008
- The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the ElderlyDrug Safety, 2007
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly PersonsAnnals of Internal Medicine, 1987